@article{eba57e215e474bdd8735911619a971af,
title = "Ventricular Fibrillation, Automatic External Defibrillators, and the United States Food and Drug Administration: Confrontation Without Comprehension",
abstract = "[Cummins RO, White RD, Pepe PE: Ventricular fibrillation, automatic external defibrillators, and the United States Food and Drug Administration: Confrontation without comprehension. Ann Emerg Med November 1995;26:621-631.].",
author = "Cummins, {Richard O.} and White, {Roger Dean} and Pepe, {Paul E.}",
note = "Funding Information: Paul E Pepe, MD, MPH has conducted research in critical care and resuscitation medicine for the past 15 years, particularly in the area of out-of-hospital cardiac arrest. He is a municipal government employee (director of EMS for the city of Houston) and a tenured faculty member of Baylor College of Medicine. He is director of the Houston Center for Resuscitation and Emergency Medical Services and has served as a member of the AHA National Subcommittee on ACLS and as chairman of the Emergency Cardiac Care Committee for the AHA Gulf Coast Council. He has served as president of the National Association of Emergency Medical Services Physicians. He received training support from Laerdal Corporation (extended loan of Heartstart 3000S defibrillators for demonstration and training purposes after the city purchased the Heartstart devices for all its 130 basic life support apparatus after the standard RFP/bid process.) He was awarded a 1-year EMS fellowship grant from the Society for Academic Emergency Medicine that was sponsored, in part, by Physio-Control Corporation. He served as a member of the FDA Defibrillation Working Group in 1990 and received travel reimbursement from the American College of Emergency Physicians for that service. He receives no travel expenses or honoraria from any proprietary corporations. Funding Information: Richard O Cummins, MD, has conducted research for more than 12 years in the areas of out-of-hospital cardiac arrest and automated external defibrillation. Dr Cummins is the co-director of the Center for Evaluation of Emergency Medical Services (CEEMS). Over these years CEEMS has received research support from the National Center for Health Services Research, the Agency for Health Care and Policy Research, the Laerdal Foundation for Acute Medicine, the Medic One Foundation, the National American Heart Association (AHA), the Washington State AHA, and the following companies that manufacture defibrillators: Cardiac Resuscitator Corporation, Physio-Control Corporation, Laerdal Medical Company, First Medic Company, Zoll Corporation, Hewlett-Packard Company, and Heartstream Company. He has participated in conferences and symposia sponsored by one or more of these companies and has received honoraria and travel and accommodation expenses related to these conferences. He has a Commissioner's Special Citation from the US Food and Drug Administration (FDA) for his work as a member of the FDA's Defibrillator Working Group and has received travel and accommodation expenses from the FDA; the National Highway and Traffic Safety Administration; and the National Heart, Lung, and Blood Institute. Dr Cummins testified as an expert witness in the Federal District Court trial (CV93-1141-FR) United States v Laerdal Manufacturing Corporation . He testified on behalf of Laerdal Manufacturing Corporation and was reimbursed for expenses and received a fee for professional time. ",
year = "1995",
month = nov,
doi = "10.1016/S0196-0644(95)70015-3",
language = "English (US)",
volume = "26",
pages = "621--631",
journal = "Annals of emergency medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "5",
}